Development of nanocrystal formulation of mebendazole with improved dissolution and pharmacokinetic behaviors

被引：0
|
作者：
Naofumi Hashimoto [1 ]
Kayo Yuminoki [1 ]
Haruka Takeuchi [1 ]
Chiaki Okada [1 ]
机构：
[1] Setsunan University
来源：
AsianJournalofPharmaceuticalSciences | 2016年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R943 [制剂学];
学科分类号：
100602 ; 100702 ;
摘要：
Nanosizing by wet beads milling is a method to improve the solubility of poorly water soluble compounds [1,2]. Mebendazole(MBZ) is a well-known anthelmintic drug in wide clinical use.There were some reports that MBZ had the anticancer effect in preclinical study. However, the bioavailability of MEB is low(<10%) due to the poor solubility in water (0.5μg/mL). The present study aimed to develop the nanocrystal formula-
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [1] Development of nanocrystal formulation of meloxicam with improved dissolution and pharmacokinetic behaviors
    Ochi, Masanori
    Kawachi, Takaki
    Toita, Eri
    Hashimoto, Issei
    Yuminoki, Kayo
    Onoue, Satomi
    Hashimoto, Naofumi
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 474 (1-2) : 151 - 156
  • [2] Development of Meloxicam Salts with Improved Dissolution and Pharmacokinetic Behaviors in Rats with Impaired Gastric Motility
    Ochi, Masanori
    Inoue, Ryo
    Yamauchi, Yukinori
    Yamada, Shizuo
    Onoue, Satomi
    PHARMACEUTICAL RESEARCH, 2013, 30 (02) : 377 - 386
  • [3] Development of Meloxicam Salts with Improved Dissolution and Pharmacokinetic Behaviors in Rats with Impaired Gastric Motility
    Masanori Ochi
    Ryo Inoue
    Yukinori Yamauchi
    Shizuo Yamada
    Satomi Onoue
    Pharmaceutical Research, 2013, 30 : 377 - 386
  • [4] Development of Abiraterone Acetate Nanocrystal Tablets to Enhance Oral Bioavailability: Formulation Optimization, Characterization, In Vitro Dissolution and Pharmacokinetic Evaluation
    Liu, Yuanfen
    Li, Yuqi
    Xu, Pengcheng
    Shen, Yan
    Tang, Baoqiang
    Wang, Qiyue
    PHARMACEUTICS, 2022, 14 (06)
  • [5] Development and characterization of glimepiride nanocrystal formulation and evaluation of its pharmacokinetic in rats
    Du, Bin
    Shen, Guopeng
    Wang, Dandan
    Pang, Li
    Chen, Zheng
    Liu, Zhongying
    DRUG DELIVERY, 2013, 20 (01) : 25 - 33
  • [6] Bexarotene nanocrystal-Oral and parenteral formulation development, characterization and pharmacokinetic evaluation
    Chen, Lijiang
    Wang, Yongjie
    Zhang, Jiaozhen
    Hao, Leilei
    Guo, Hejian
    Lou, Hongxiang
    Zhang, Dianrui
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 87 (01) : 160 - 169
  • [7] Dissolution enhancement of albendazole through nanocrystal formulation
    Krishna, D. Koradia
    Rajesh, H. Parikh
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2012, 4 (05): : S62 - S63
  • [8] Formulation development of chewable albendazole tablets with improved dissolution rate
    Kimaro, Emmanuel
    Tibalinda, Prosper
    Shedafa, Raphael
    Temu, Mary
    Kaale, Eliangiringa
    HELIYON, 2019, 5 (12)
  • [9] Development of novel lutein nanocrystal formulation with improved oral bioavailability and ocular distribution
    Seto, Yoshiki
    Ueno, Kodai
    Suzuki, Hiroki
    Sato, Hideyuki
    Onoue, Satomi
    JOURNAL OF FUNCTIONAL FOODS, 2019, 61
  • [10] Improved dissolution and pharmacokinetic behavior of dipyridamole formulation with microenvironmental pH-modifier under hypochlorhydria
    Onoue, Satomi
    Inoue, Ryo
    Taniguchi, Chika
    Kawabata, Yohei
    Yamashita, Kazuhiro
    Wada, Koichi
    Yamauchi, Yukinori
    Yamada, Shizuo
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 426 (1-2) : 61 - 66
12345